A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest NewsMarket Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayLatest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 42
Competitor Profiles
- 11
IOL Categories Forecasted
- 8
Geographic/Economic Breakouts
Latest Industry News & Trends
4/14/2021
Press Release
US Cataract Pharmaceuticals Evolve in Drug Delivery
US cataract surgeons showed a preference for incremental improvement in drug delivery over revolutionary change in the first full year for three new corticosteroid products to manage inflammation a...
4/16/2021
BreakingDealsInstrumentsSurgical
Katena Buys ASICO, Building on Roster of Recent Acquisitions
Katena Products announced April 14 that it had purchased fellow ophthalmic surgical instrument maker ASICO, of Westmont, Illinois. The companies said ASICO’s product portfolio comprises more than 1...
4/16/2021
BreakingDealsPharmaRetina
Alimera Licenses its Steroid Implant to Ocumension for Asian Markets, Receives $20 Million
Alimera Sciences announced April 14 that China’s Ocumension Therapeutics had paid $10 million up front to license Alimera’s 0.19 mg fluocinolone acetonide intravitreal implant, which Alimera market...
4/16/2021
BreakingClinical TrialDry EyePharma
Bausch + Lomb Dry Eye Candidate Licensed from Novaliq Meets All Endpoints in Phase III Trial
Bausch + Lomb, a division of Canada’s Bausch Health, and Germany’s Novaliq announced April 13 statistically significant topline data from the first Phase III trial of NOV03 (perfluorohexyloctane) f...
4/16/2021
BreakingDiagnostic
AAO, NEI, Others Urge Ophthalmic Equipment Manufacturers to Standardize Digital Imaging
The American Academy of Ophthalmology published a report April 5 urging ophthalmic imaging device manufacturers to standardize image formats to comply with the Digital Imaging and Communications in...
4/16/2021
BreakingCataractRegulationSurgical
J&J Vision Surgical Gains US Clearance for Veritas Next-Generation Phaco System
Johnson & Johnson Vision Surgical gained US FDA 510(k) clearance on March 12 for its Veritas Vision System. The phacoemulsification system is an updated version of the company’s WhiteStar Signature...
4/16/2021
BreakingCataractIOLSurgical
Alcon Introduces UV-Filtering Versions of PanOptix, Vivity IOLs in Canada
Alcon announced on April 12 that it had launched in Canada four next-generation IOLs to provide ultraviolet (UV)-filtering hydrophobic protection. The models are the AcrySof IQ PanOptix UV intraocu...
4/16/2021
BreakingDealsGene TherapyRetina
AGTC Licenses X-Linked Retinoschisis Gene Therapy Program to TeamedOn
Applied Genetic Technologies Corporation (AGTC) announced April 13 that it had reached a licensing deal with TeamedOn International to advance a gene therapy candidate to treat X-linked retinoschis...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.